HEADER TRANSFERASE 24-APR-23 8J61 TITLE THE CRYSTAL STRUCTURE OF TRKA KINASE IN COMPLEX WITH 4^6-METHYL-N-(3- TITLE 2 (4-METHYL-1H-IMIDAZOL-1-YL)-5-(TRIFLUOROMETHYL)PHENYL)-14-OXO-5-OXA- TITLE 3 13-AZA-1(3,6)-IMIDAZO[1,2-B]PYRIDAZINA-4(1,3)- TITLE 4 BENZENACYCLOTETRADECAPHAN-2-YNE-4^5-CARBOXAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: NEUROTROPHIC TYROSINE KINASE RECEPTOR TYPE 1,TRK1- COMPND 5 TRANSFORMING TYROSINE KINASE PROTEIN,TROPOMYOSIN-RELATED KINASE A, COMPND 6 TYROSINE KINASE RECEPTOR,TYROSINE KINASE RECEPTOR A,TRK-A,GP140TRK, COMPND 7 P140-TRKA; COMPND 8 EC: 2.7.10.1; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NTRK1, MTC, TRK, TRKA; SOURCE 6 EXPRESSION_SYSTEM: BACULOVIRUS EXPRESSION VECTOR PFASTBAC1-HM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 274590 KEYWDS TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR Z.M.ZHANG,Y.J.WANG REVDAT 2 11-OCT-23 8J61 1 JRNL REVDAT 1 20-SEP-23 8J61 0 JRNL AUTH Z.WANG,J.WANG,Y.WANG,S.XIANG,H.ZHOU,S.SONG,X.SONG,Z.TU, JRNL AUTH 2 Y.ZHOU,K.DING,Z.M.ZHANG,Z.ZHANG,X.LU JRNL TITL STRUCTURE-BASED OPTIMIZATION OF THE THIRD GENERATION TYPE II JRNL TITL 2 MACROCYCLE TRK INHIBITORS WITH IMPROVED ACTIVITY AGAINST JRNL TITL 3 SOLVENT-FRONT, XDFG, AND GATEKEEPER MUTATIONS. JRNL REF J.MED.CHEM. V. 66 12950 2023 JRNL REFN ISSN 0022-2623 JRNL PMID 37676745 JRNL DOI 10.1021/ACS.JMEDCHEM.3C00899 REMARK 2 REMARK 2 RESOLUTION. 3.05 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692+SVN REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.05 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.86 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.344 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 6942 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.209 REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.255 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.968 REMARK 3 FREE R VALUE TEST SET COUNT : 692 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 10.0000 - 5.2052 0.98 1287 143 0.2183 0.2792 REMARK 3 2 5.2052 - 4.1370 1.00 1274 143 0.1787 0.2094 REMARK 3 3 4.1370 - 3.6156 1.00 1242 138 0.1858 0.2205 REMARK 3 4 3.6156 - 3.2858 1.00 1224 135 0.2147 0.2756 REMARK 3 5 3.2858 - 3.0507 1.00 1223 133 0.2486 0.3303 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.348 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.036 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 53.06 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 52.73 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.004 2409 REMARK 3 ANGLE : 0.830 3268 REMARK 3 CHIRALITY : 0.029 344 REMARK 3 PLANARITY : 0.003 420 REMARK 3 DIHEDRAL : 17.449 877 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 499 THROUGH 644 ) REMARK 3 ORIGIN FOR THE GROUP (A): -9.9877 0.1815 15.3968 REMARK 3 T TENSOR REMARK 3 T11: 0.3205 T22: 0.2900 REMARK 3 T33: 0.4113 T12: 0.0222 REMARK 3 T13: -0.0018 T23: 0.0152 REMARK 3 L TENSOR REMARK 3 L11: 0.3406 L22: 3.4582 REMARK 3 L33: 2.2355 L12: -0.0902 REMARK 3 L13: -0.2456 L23: -0.7648 REMARK 3 S TENSOR REMARK 3 S11: 0.0595 S12: -0.0304 S13: 0.1202 REMARK 3 S21: 0.0747 S22: -0.3059 S23: -0.2754 REMARK 3 S31: -0.3785 S32: 0.0524 S33: 0.1840 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 645 THROUGH 795 ) REMARK 3 ORIGIN FOR THE GROUP (A): -14.3285 -20.0717 23.8072 REMARK 3 T TENSOR REMARK 3 T11: 0.4811 T22: 0.2596 REMARK 3 T33: 0.3244 T12: 0.0492 REMARK 3 T13: 0.0704 T23: 0.0521 REMARK 3 L TENSOR REMARK 3 L11: 2.2320 L22: 1.1452 REMARK 3 L33: 3.0192 L12: -0.0492 REMARK 3 L13: -1.6079 L23: -0.0686 REMARK 3 S TENSOR REMARK 3 S11: -0.2671 S12: -0.2547 S13: -0.2855 REMARK 3 S21: 0.1800 S22: -0.0162 S23: -0.2122 REMARK 3 S31: 0.2625 S32: 0.1557 S33: 0.1780 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8J61 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBC ON 10-MAY-23. REMARK 100 THE DEPOSITION ID IS D_1300037268. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-SEP-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CAMD REMARK 200 BEAMLINE : GCPCC REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.978 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX-300 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 6942 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.050 REMARK 200 RESOLUTION RANGE LOW (A) : 25.900 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 19.60 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.1400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.05 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.16 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.76 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.60 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M NA2HPO4/KH2PO4 (PH 6.2), 2M NACL, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 1 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -Y,-X,-Z+2/3 REMARK 290 5555 -X+Y,Y,-Z+1/3 REMARK 290 6555 X,X-Y,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 76.19733 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 152.39467 REMARK 290 SMTRY1 4 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 152.39467 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 76.19733 REMARK 290 SMTRY1 6 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 498 REMARK 465 GLU A 548 REMARK 465 ALA A 549 REMARK 465 ALA A 608 REMARK 465 LYS A 609 REMARK 465 LEU A 610 REMARK 465 LEU A 611 REMARK 465 GLY A 796 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 555 CG CD OE1 NE2 REMARK 470 ARG A 559 CG CD NE CZ NH1 NH2 REMARK 470 MET A 671 CG SD CE REMARK 470 ILE A 675 CG1 CG2 CD1 REMARK 470 ARG A 682 CG CD NE CZ NH1 NH2 REMARK 470 PHE A 704 CG CD1 CD2 CE1 CE2 CZ REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 CYS A 501 SG REMARK 480 ARG A 508 CZ NH1 NH2 REMARK 480 ILE A 510 CD1 REMARK 480 PHE A 521 CG CD1 CD2 CE1 CE2 CZ REMARK 480 LYS A 538 CE NZ REMARK 480 LEU A 546 CD1 CD2 REMARK 480 LYS A 547 CD CE NZ REMARK 480 GLU A 551 CG CD OE1 OE2 REMARK 480 SER A 552 OG REMARK 480 ARG A 554 CD NE CZ NH1 NH2 REMARK 480 GLN A 558 CD OE1 NE2 REMARK 480 MET A 566 CG SD CE REMARK 480 ARG A 599 CD NE CZ NH1 NH2 REMARK 480 MET A 638 CE REMARK 480 LEU A 644 CD1 CD2 REMARK 480 ARG A 686 CG CD NE CZ NH1 NH2 REMARK 480 MET A 688 CE REMARK 480 LYS A 725 CD CE NZ REMARK 480 ARG A 750 NE CZ NH1 NH2 REMARK 480 ARG A 761 CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 531 17.77 55.78 REMARK 500 GLU A 581 96.81 -62.47 REMARK 500 ARG A 649 -21.87 66.53 REMARK 500 MET A 671 -74.57 86.00 REMARK 500 TYR A 676 49.47 -107.79 REMARK 500 VAL A 794 42.15 -106.78 REMARK 500 REMARK 500 REMARK: NULL DBREF 8J61 A 498 796 UNP P04629 NTRK1_HUMAN 498 796 SEQRES 1 A 299 SER ASP ALA CYS VAL HIS HIS ILE LYS ARG ARG ASP ILE SEQRES 2 A 299 VAL LEU LYS TRP GLU LEU GLY GLU GLY ALA PHE GLY LYS SEQRES 3 A 299 VAL PHE LEU ALA GLU CYS HIS ASN LEU LEU PRO GLU GLN SEQRES 4 A 299 ASP LYS MET LEU VAL ALA VAL LYS ALA LEU LYS GLU ALA SEQRES 5 A 299 SER GLU SER ALA ARG GLN ASP PHE GLN ARG GLU ALA GLU SEQRES 6 A 299 LEU LEU THR MET LEU GLN HIS GLN HIS ILE VAL ARG PHE SEQRES 7 A 299 PHE GLY VAL CYS THR GLU GLY ARG PRO LEU LEU MET VAL SEQRES 8 A 299 PHE GLU TYR MET ARG HIS GLY ASP LEU ASN ARG PHE LEU SEQRES 9 A 299 ARG SER HIS GLY PRO ASP ALA LYS LEU LEU ALA GLY GLY SEQRES 10 A 299 GLU ASP VAL ALA PRO GLY PRO LEU GLY LEU GLY GLN LEU SEQRES 11 A 299 LEU ALA VAL ALA SER GLN VAL ALA ALA GLY MET VAL TYR SEQRES 12 A 299 LEU ALA GLY LEU HIS PHE VAL HIS ARG ASP LEU ALA THR SEQRES 13 A 299 ARG ASN CYS LEU VAL GLY GLN GLY LEU VAL VAL LYS ILE SEQRES 14 A 299 GLY ASP PHE GLY MET SER ARG ASP ILE TYR SER THR ASP SEQRES 15 A 299 TYR TYR ARG VAL GLY GLY ARG THR MET LEU PRO ILE ARG SEQRES 16 A 299 TRP MET PRO PRO GLU SER ILE LEU TYR ARG LYS PHE THR SEQRES 17 A 299 THR GLU SER ASP VAL TRP SER PHE GLY VAL VAL LEU TRP SEQRES 18 A 299 GLU ILE PHE THR TYR GLY LYS GLN PRO TRP TYR GLN LEU SEQRES 19 A 299 SER ASN THR GLU ALA ILE ASP CYS ILE THR GLN GLY ARG SEQRES 20 A 299 GLU LEU GLU ARG PRO ARG ALA CYS PRO PRO GLU VAL TYR SEQRES 21 A 299 ALA ILE MET ARG GLY CYS TRP GLN ARG GLU PRO GLN GLN SEQRES 22 A 299 ARG HIS SER ILE LYS ASP VAL HIS ALA ARG LEU GLN ALA SEQRES 23 A 299 LEU ALA GLN ALA PRO PRO VAL TYR LEU ASP VAL LEU GLY HET A0X A 801 48 HETNAM A0X 4^6-METHYL-N-(3-(4-METHYL-1H-IMIDAZOL-1-YL)-5- HETNAM 2 A0X (TRIFLUOROMETHYL)PHENYL)-14-OXO-5-OXA-13-AZA-1(3,6)- HETNAM 3 A0X IMIDAZO[1,2-B]PYRIDAZINA-4(1,3)- HETNAM 4 A0X BENZENACYCLOTETRADECAPHAN-2-YNE-4^5-CARBOXAMIDE FORMUL 2 A0X C35 H32 F3 N7 O3 HELIX 1 AA1 LYS A 506 ARG A 508 5 3 HELIX 2 AA2 GLU A 551 LEU A 567 1 17 HELIX 3 AA3 ASP A 596 HIS A 604 1 9 HELIX 4 AA4 GLY A 623 LEU A 644 1 22 HELIX 5 AA5 ALA A 652 ARG A 654 5 3 HELIX 6 AA6 MET A 671 TYR A 676 1 6 HELIX 7 AA7 SER A 677 TYR A 680 5 4 HELIX 8 AA8 PRO A 690 MET A 694 5 5 HELIX 9 AA9 PRO A 695 LEU A 700 1 6 HELIX 10 AB1 THR A 705 THR A 722 1 18 HELIX 11 AB2 SER A 732 GLN A 742 1 11 HELIX 12 AB3 PRO A 753 TRP A 764 1 12 HELIX 13 AB4 GLU A 767 ARG A 771 5 5 HELIX 14 AB5 SER A 773 ALA A 787 1 15 HELIX 15 AB6 PRO A 788 VAL A 794 1 7 SHEET 1 AA1 5 ILE A 510 GLU A 518 0 SHEET 2 AA1 5 LYS A 523 HIS A 530 -1 O VAL A 524 N LEU A 516 SHEET 3 AA1 5 LYS A 538 ALA A 545 -1 O VAL A 543 N PHE A 525 SHEET 4 AA1 5 LEU A 586 GLU A 590 -1 O PHE A 589 N ALA A 542 SHEET 5 AA1 5 PHE A 575 CYS A 579 -1 N GLY A 577 O VAL A 588 SHEET 1 AA2 2 CYS A 656 GLY A 659 0 SHEET 2 AA2 2 VAL A 663 ILE A 666 -1 O VAL A 663 N GLY A 659 SHEET 1 AA3 2 TYR A 681 ARG A 682 0 SHEET 2 AA3 2 MET A 688 LEU A 689 -1 O LEU A 689 N TYR A 681 CISPEP 1 ARG A 583 PRO A 584 0 3.60 CISPEP 2 PRO A 606 ASP A 607 0 -11.09 CISPEP 3 PHE A 669 GLY A 670 0 -4.80 CISPEP 4 GLY A 670 MET A 671 0 6.59 CISPEP 5 GLY A 684 GLY A 685 0 6.33 CISPEP 6 GLY A 685 ARG A 686 0 -0.30 CRYST1 51.729 51.729 228.592 90.00 90.00 120.00 P 31 1 2 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019332 0.011161 0.000000 0.00000 SCALE2 0.000000 0.022322 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004375 0.00000